Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001266173 | SCV001444345 | uncertain significance | Inborn genetic diseases | 2018-06-20 | criteria provided, single submitter | clinical testing | |
Centogene AG - |
RCV001810009 | SCV002059613 | likely pathogenic | Intellectual disability, autosomal dominant 5 | 2021-02-04 | criteria provided, single submitter | clinical testing | |
Genome |
RCV001265526 | SCV001443670 | uncertain significance | Complex neurodevelopmental disorder | 2018-09-28 | no assertion criteria provided | provider interpretation | Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2018-09-28 and interpreted as Variant of Uncertain significance. Variant was initially reported on 2018-07-06 by GTR ID of laboratory name 61756. The reporting laboratory might also submit to ClinVar. |